申请人:The United States of America as represented by the Department of Health and Human Services
公开号:US06187775B1
公开(公告)日:2001-02-13
The present invention relates to several novel acridone-derived compounds of of formula (I) or (II). These compounds are potent anti-viral agents, useful in the treatment of viral diseases, such as Human Immunodeficiency Virus. In addition, these compounds are anti-neoplastic agents useful in the treatment of various forms of cancer.
wherein R1 and R2 are independently —H, —OH, amino, alkylamino, dialkylamino, alkoxy, alkyl, haloalkyl or halogen; n is 2 to 6, X and X′ are independently —N or —NO2; Y and Y′ are independently —N or —CH, or —H; and the double-slash represents a double bond or no bond.
本发明涉及到几种新的衍生自吖啶酮的化合物,其化学式为(I)或(II)。这些化合物是有效的抗病毒剂,可用于治疗病毒性疾病,如人类免疫缺陷病毒。此外,这些化合物还是抗肿瘤剂,可用于治疗各种形式的癌症。其中,R1和R2独立地为—H、—OH、氨基、烷基氨基、二烷基氨基、烷氧基、烷基、卤代烷基或卤素;n为2至6,X和X'独立地为—N或—NO2;Y和Y'独立地为—N或—CH,或—H;双斜杠表示双键或无键。